Supplement: TX SB2212 | 2023-2024 | 88th Legislature | Fiscal Note (Introduced)
For additional supplements on Texas SB2212 please see the Bill Drafting List
Bill Title: Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
Status: 2023-05-06 - Referred to Public Health [SB2212 Detail]
Download: Texas-2023-SB2212-Fiscal_Note_Introduced_.html
Bill Title: Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
Status: 2023-05-06 - Referred to Public Health [SB2212 Detail]
Download: Texas-2023-SB2212-Fiscal_Note_Introduced_.html
TO: |
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services |
FROM: |
Jerry McGinty, Director, Legislative Budget Board
|
IN RE: |
SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced |
No significant fiscal implication to the State is anticipated.
Based on the analysis of the Board of Pharmacy, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: b > td > | 515 Board of Pharmacy |
LBB Staff: b > td > | JMc, NPe, SLee |